Inhibition of glyoxalase I: The first low-nanomolar tight-binding inhibitors

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

A series of rational modifications to the structure of known S-(N-aryl-N-hydroxycarbamoyl)glutathione-based glyoxalase I inhibitors culminated in the discovery of the first single-digit nanomolar inhibitor. This study makes available key information about possible means to address the issues of metabolic instability, low potency, and synthetic complexicity that have plagued the area of glyoxalase I inhibition. Knowledge garnered from this study has implications in the design of inhibitors with higher conformational definition and lower peptidic character.

Original languageEnglish (US)
Pages (from-to)4650-4656
Number of pages7
JournalJournal of medicinal chemistry
Volume52
Issue number15
DOIs
StatePublished - Aug 13 2009

Fingerprint Dive into the research topics of 'Inhibition of glyoxalase I: The first low-nanomolar tight-binding inhibitors'. Together they form a unique fingerprint.

Cite this